You have 9 free searches left this month | for more free features.

Aberration control

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Tumors Trial (ABN401)

Not yet recruiting
  • Neoplasms
  • (no location specified)
May 21, 2023

Myopia, Progressive Trial in Shenyang (0.01% atropine eye drop)

Not yet recruiting
  • Myopia, Progressive
  • 0.01% atropine eye drop
  • Shenyang, Liaoning, China
    He Eye Hospital
Oct 2, 2023

Pseudophakia Trial in Houston (Visual Acuity, Biometric Data Collection, Patient Questionnaire)

Completed
  • Pseudophakia
  • Visual Acuity
  • +2 more
  • Houston, Texas
    Berkeley Eye Center
Nov 7, 2022

Salivary Gland Cancer, Metastatic, Advanced Trial in Toronto (Selinexor, EGFR or HER2 Inhibitor, FGFR Inhibitor)

Recruiting
  • Salivary Gland Cancer
  • +3 more
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Feb 18, 2022

Evaluation of Cataract Surgery Outcome

Recruiting
  • Cataract
  • High Myopia
    • Shanghai, Shanghai, China
      Eye and ENT Hospital of Fudan University
    Aug 18, 2021

    Optical Quality During the Peak of the Covid-19 Pandemic

    Completed
    • Corneal Wavefront Aberration
    • SARS-CoV-2
      • Tianjin, Tianjin, China
        Tianjin Eye Hospital
      May 27, 2023

      Pseudophakia Trial in Houston (Visual Acuity, Defocus Curve, Intraocular Lens Satisfaction (IOLSAT) Questionnaire)

      Recruiting
      • Pseudophakia
      • Visual Acuity
      • +5 more
      • Houston, Texas
        Berkeley Eye Center
      Sep 26, 2023

      Visual Acuity Trial in Waterloo (etafilcon A, Habitual Orthokeratology Lenses)

      Completed
      • Visual Acuity
      • etafilcon A
      • Habitual Orthokeratology Lenses
      • Waterloo, Ontario, Canada
        Centre for Ocular Research & Education
      Dec 16, 2021

      Central and Peripheral Wavefront Aberration Profile in Pediatric

      Not yet recruiting
      • Myopia
      • Intervention
      • Houston, Texas
        University of Houston College of Optometry - J. Armistead Bldg R
      Oct 9, 2023

      Lung Cancer Squamous Cell Trial in London (Electrocautery Ablation (EC))

      Terminated
      • Lung Cancer Squamous Cell
      • Electrocautery Ablation (EC)
      • London, United Kingdom
        UCLH
      Oct 27, 2022

      Coronary Artery Disease, Dyslipidemias Trial in Yongin (a high dose of statin/ezetimib)

      Recruiting
      • Coronary Artery Disease
      • Dyslipidemias
      • a high dose of statin/ezetimib
      • Yongin, Gyeonggi-do, Korea, Republic of
        Yongin Severance Hospital
      Jun 14, 2023

      Schizophrenia, Mental Disorders, Psychotic Disorders Trial in West Haven (THC and Iomazenil, Placebo (control))

      Completed
      • Schizophrenia
      • +2 more
      • THC and Iomazenil
      • Placebo (control)
      • West Haven, Connecticut
        VA Connecticut Healthcare System
      Dec 2, 2022

      Myopic Progression Trial in Tianjin (Orthokeratology lens)

      Recruiting
      • Myopic Progression
      • Orthokeratology lens
      • Tianjin, Tianjin, China
        Tianjin Eye Hospital
      Dec 30, 2021

      Clinical Utility of Oncomine Precision Assay Within Exactis

      Recruiting
      • NSCLC
        • Moncton, New Brunswick, Canada
        • +6 more
        Dec 9, 2022

        Schizophrenia, Schizoaffective Disorder Trial in Poitiers (Electroencephalogram)

        Recruiting
        • Schizophrenia
        • Schizoaffective Disorder
        • Electroencephalogram
        • Poitiers, France
          Centre Hospitalier Henri Laborit
        Jul 18, 2022

        Myopia Trial in Guangzhou (New defocus spectacle lenses, Convenional aspheric single-vision spectacle lenses)

        Not yet recruiting
        • Myopia
        • New defocus spectacle lenses
        • Convenional aspheric single-vision spectacle lenses
        • Guangzhou, Guangdong, China
          Zhongshan Ophthalmic Center, Sun Yat-sen University
        Feb 13, 2023

        Advanced Pancreatic Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8 Trial in

        Recruiting
        • Advanced Pancreatic Carcinoma
        • +27 more
        • Gainesville, Florida
        • +3 more
        Jan 3, 2023

        Myopia Trial in Tianjin (Orthokeratology with aspheric wide inversion zone design in the optical zone, Orthokeratology with

        Completed
        • Myopia
        • Orthokeratology with aspheric wide inversion zone design in the optical zone
        • Orthokeratology with traditional spherical design in the optical zone
        • Tianjin, China
          Tianjin Eye Hospital
        Jul 14, 2023

        After Corneal Refractive Surgery

        Completed
        • Myopia
        • Refractive surgery
        • Tanta, El-Garbeia, Egypt
          Tanta University Hospital
        Feb 7, 2022

        Prostatic Hyperplasia Trial in Banha (Chromax, Sildosin Group, Placebo Group)

        Recruiting
        • Prostatic Hyperplasia
        • Banhā, Kalubyia, Egypt
          Banha University Hospitals
        Nov 9, 2022

        Emmetropia, Myopia Trial in Houston (White Light therapy, Blue light therapy, Red light therapy)

        Completed
        • Emmetropia
        • Myopia
        • White Light therapy
        • +3 more
        • Houston, Texas
          University of Houston College of Optometry
        May 7, 2023

        Cancer (With or Without Metastasis) Trial in Houston (TSN084)

        Recruiting
        • Cancer (With or Without Metastasis)
        • Houston, Texas
          MD Anderson Cancer Center
        Apr 22, 2022

        Visual Quality Trial in Guangdong

        Recruiting
        • Visual Quality
          • Guangdong, Guangzhou, China
            First Affiliated Hospital of Jinan University
          Jun 16, 2021

          Contact Lens Wearer Trial in Rochester (kalifilcon A Daily Disposable Toric LD213001 lens in SKUs +6D, +3D, 0D, -3D, -6D, and

          Completed
          • Contact Lens Wearer
          • kalifilcon A Daily Disposable Toric LD213001 lens in SKUs +6D, +3D, 0D, -3D, -6D, and -9D
          • Rochester, New York
            Bausch and Lomb Site 01
          Nov 10, 2021

          MDS Trial in Innsbruck (Next Generation Sequencing, Tumorimmunological examinations - multiplex assays/quantitative polymerase

          Recruiting
          • Myelodysplastic Syndromes
          • Next Generation Sequencing
          • +5 more
          • Innsbruck, Tyrol, Austria
            Medical University of Innsbruck
          Apr 6, 2022